newsfilter
← Latest News
Business Wire·

Lantern Pharma to Present Open-Medicine AI — a Multi-Agentic Platform for End-to-End Therapeutic Development — Business Model, Roadmap, and Value Proposition on September 23

Built Inside Active Clinical Programs: A New Generation of AI Co-Scientists Designed to Compress Research Timelines and Expand What Is Possible in Drug Development Open-Medicine AI Founder & CEO Panna Sharma to